ANZSNM 2015

Invited Speakers

Details of confirmed speakers will be added as arrangements are confirmed.

International Speakers

Hojjat AhmadzadehfarHojjat Ahmadzadehfar, M.D.

Associate Professor, Department of Nuclear Medicine,University Hospital Bonn, Germany

D: Guilan University of Medical Science (Iran) 1999
Residency: Department of Nuclear Medicine; University Hospital Bonn Germany 2003-2008
Board Certification: Nuclear Medicine 2008

Actual Position: Attending physician and assistant director of the department of Nuclear Medicine since 2009 (Director: Prof. Dr. M. Essler)

Reviewer for:

  1. Journal of Nuclear Medicine
  2. European Radiology
  3. Nuklearmedizin
  4. Thyroid
  5. Physica Medica
  6. BMC cancer

Hojjat Ahmadzadehfar, M.D. is proudly sponsored by Sirtex
Sirtex

Michael KnoppDr. Michael Knopp, MD,PhD

Professor, Vice Chair of Research, Director – Wright Center for Innovation, USA

Dr. Knopp has a long track record of developing and validating new imaging methodologies with a special interest in MRI, PET and safety. His scientific focus has been imaging of angiogenesis and response assessment. His current research focus is on functional and molecular hybrid imaging based assessment as well as validation of imaging methodologies as biomarkers. He has been extensively funded for developing, analyzing and performing imaging-based analysis to diagnose and assess therapies. With the initial funding of the Wright Center of Innovation in Biomedical Imaging, he has been able to build up an extensive infrastructure that provides state-of-the-art capabilities to perform advanced imaging studies as well as their analysis.

Dr. Michael Knopp is proudly sponsored by Insight

Insight

John MahmarianJohn J. Mahmarian, M.D

Senior Member, The Methodist Hospital Research Institute, Chief, Division of Nuclear Cardiology and CT Services, Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, USA

Dr. Mahmarian received his first faculty appointment in 1987 as an Instructor of Medicine at the Baylor College of Medicine in Houston, Texas. He quickly established himself as a leader in nuclear cardiology research and was promoted to full Professor in 2005 just prior to joining the Methodist Hospital Physician Organization and the faculty of the Weill Medical College of Cornell University. Dr. Mahmarian´s early research efforts focused on quantification of ischemia as measured by SPECT sestimibi, thereby laying the groundwork for the use of this technique in international trials of ischemia. His current research is focused on combining the results of CT acquired coronary angiography with SPECT results (fusion imaging), as well as testing new agents for pharmacologic stress testing and imaging modalities (e.g. "hot spot" imaging).

Frank RoschProf. Frank Rösch

Institute of Nuclear Chemistry, Johannes Gutenberg-University Mainz, Germany

Professor Frank Rösch(born 1955) is professor for Nuclear Chemistry, Institute of Nuclear Chemistry, Johannes Gutenberg-University Mainz, Germany. He is also Co-ordinator, working group leader or vice-chair of various COST (European Cooperation in Science and Technology) actions related to radiometals and their medical application: D18: lanthanide chemistry for diagnosis and therapy; D38: metal-based systems for molecular imaging applications; BMC0607: from dosimetry to biological effect: Radiobiology as guide to clinical practice in nuclear medicine and TD1004: theragnostics imaging and therapy: an action to develop novel nanosized systems for imaging-guided drug delivery.

He is a member of the working group Radiopharmaceuticals of the The Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte), co-ordinator of the International Student Exchange Program for Nuclear Chemistry / Radiopharmaceutical Chemistry between the University Mainz and the Brookhaven National Laboratory, USA, expert of the IAEA, the International Atomic Energy Agency, managing director of the Institute of Nuclear Chemistry.

Markus SchwaigerProf. Dr. Markus Schwaiger

Chair, Nuclear Medical Clinic and Policlinic, Technische Universität München

Prof. Schwaiger (b. 1950) received his medical training at the Medical School of the Free University of Berlin, Germany, and completed a fellowship at the division of nuclear medicine, UCLA School of Medicine, Los Angeles. He served as assistant professor of radiological sciences, division of nuclear medicine, UCLA School of Medicine, professor of medicine, division of nuclear medicine, University of Michigan and professor and director, department of nuclear medicine, Technische Universitaet of Munich, Germany. He is currently dean of the School of Medicine, Technische Universitaet Muenchen, Germany. He has published 750 peer-reviewed publications in international scientific journals, over 100 book chapters and has been invited to give more than 500 presentations. His work is frequently cited (H-Factor 97).

Prof. Markus Schwaiger is proudly sponsored by Siemens

Siemens

Australian Speakers

R Howman-GilesProfessor Robert Howman-Giles

Clinical Professor, Discipline of Medical Imaging and Discipline of Paediatrics and Child Health, University of Sydney

Professor Robert Howman-Giles is a Clinical Professor in the Discipline of Medical Imaging and Discipline of Paediatrics and Child Health, University of Sydney. He is Head of the Department of Nuclear Medicine at the Children’s Hospital at Westmead and a Director of Alfred Nuclear Medicine and Ultrasound, RPAH Medical Centre, Newtown, NSW. He has published extensively on the use of nuclear medicine and bone mineral density with over 165 publications in peer reviewed journals, 22 book chapters and 1 book. He has presented many lectures and been an invited speaker at national and international conferences. Professor Howman-Giles has major interests in imaging and therapy in paediatric oncology especially PET/CT applications, skeletal, biliary and renal disorders. He has extensive experience in lymphatic mapping in children and in adult sentinel lymph node imaging in melanoma and breast cancer.

Vijay KumarProf. Vijay Kumar PhD

Clinical Professor, Sydney Medical School, Sydney University; Prinicpal Scientist, Department of Nuclear Medicine & PET Westmead Hospital & The Children's Hospital at Westmead

Professor Vijay Kumar is the Principal Scientist and Head of the Radiopharmaceutical Research at the Department of Nuclear Medicine at Westmead Hospital and the Children’s Hospital at Westmead. His research focus is on 68Ga-radiopharmaceuticals and their applications in the management of Cancer and infectious diseases. He has been invited to deliver many lectures at international conferences and at prestigious Universities around the world. Professor Kumar worked at International Atomic Energy Agency (IAEA) in 2010 and continued to be actively engaged in Co-ordinated Research Projects (CRP) and contributed for developing many teaching modules and scientific documents. He has active involvement with IAEA expert missions to developing countries and offered training in Radiopharmaceutical Science at Westmead & The Children’s hospitals, for many overseas candidates under IAEA Fellowship program. He has published many papers and is the recipient of research and scientific awards.

David LisleDr David Lisle MBBS, FRANZCR

Consultant Radiologist, Royal Brisbane Hospital and Brisbane Private Hospital

Trained in radiology in Brisbane and Aberdeen, Scotland. Currently employed as a Consultant Radiologist at the Royal Brisbane Hospital and Brisbane Private Hospital in Brisbane. Associate Professor in Medical Imaging, University of Queensland Medical School. Examiner in neuroradiology for the Royal Australian and New Zealand College of Radiologists Associate editor for the Journal of Medical Imaging and Radiation Oncology. Author of 6 textbooks, most recently the 4th edition of Imaging for Students Author of numerous original and review articles. Professional interests include paediatric radiology, oncological imaging, and MRI.

Ken MilesKen Miles

Senior Medical Officer, Princess Alexandra Hospital, Brisbane

Ken Miles is Senior Medical Officer at the Princess Alexandra Hospital, Brisbane, and Professorial Research Associate in the Institute of Nuclear Medicine, Univeristy College London. He is dual-trained in Radiology and Nuclear Medicine and undertakes research in Australia and the UK, whilst conducting clinical work in Australia. He has been either priniple investigator or associate investigator for research grants in Australia and the UK totaling more than $5million. Ken's scientific interests lie in the functional imaging of tumours, ranging from the development of new techniques through to demonstrating cost-effectiveness. He has wide experience in Positron Emission Tomography, having been involved in the establishment of four PET centres worldwide, including the PET/MRI system at PAH. He previously served on the Technical Advisory Committe for the Australian government's PET reveiw and completed a term as co-lead of the UK National Cancer Research Institute's PET Research Network. He has authored or co-authored more than 100 peer-reviewed scientific publications and contributed to or edited 11 books in Radiology. Ken Miles is co-editor in chief of the journal Cancer Imaging.

Paul ThomasAssoc. Prof. Paul Thomas

Assistant Director of Specialised PET Services Queensland

Paul is Assistant Director of Specialised PET Services Queensland, based at Royal Brisbane and Women’s Hospital, and Associate Professor with the School of Medicine at The University of Queensland. He was previously Director of Nuclear Medicine and PET at the Hunter New England Imaging Service. He underwent fellowship training at the Mayo Clinic in Rochester, Minnesota and PET training at the Clinical PET Centre at St Thomas’ Hospital in London. Paul’s research interests include FDOPA and FMISO PET imaging of high grade glioma, PSMA PET imaging in primary and recurrent prostate cancer, FDG PET staging of ovarian cancer, and technical projects in motion correction for PET, improved FDG PET kinetic analyses for liver metastases and multiplexed PET imaging.

David WongDr David Wong

Director of PET and Nuclear Medicine, Wesley Medical Imaging, The Wesley Hospital

Dr David Wong is a radiologist and PET/nuclear medicine specialist and is the Director of PET and Nuclear Medicine at Wesley Medical Imaging at The Wesley Hospital in Brisbane. He graduated from the University of Queensland Medical School and completed his radiology training at the Princess Alexandra hospital in Brisbane. He undertook a fellowship in nuclear medicine at St Vincent’s and Prince of Wales Hospitals in Sydney, and PET training at Peter MacCallum Cancer Institute in Melbourne. He also completed a fellowship in cardiac MRI at Barnes-Jewish Hospital in St Louis, Missouri, and obtained his MBA from Central Queensland University. David has been with the first PET facility in Queensland – The Wesley PET Centre since 1999. He has published numerous papers and is the recipient of several research and scientific awards, including the Rouse Travelling Fellowship and Brain Smith Memorial award. In July 2014, David was instrumental in the setting of Ga68PSMA PET CT service at Wesley Medical Imaging, with The Wesley Hospital in Brisbane being the first centre in Australia to commence clinical Ga68PSMA PET CT studies in men with prostate cancer.

Joseph WongDr Joseph Wong FRACP, FAANMS, MBA

Nuclear Medicine Physician, Bone Densitometry at Qscan, Brisbane

Dr Joseph Wong manages the multi-centre bone densitometry service at Qscan. He is an honours graduate of the University of Queensland. He commenced his Nuclear Medicine fellowship at the Prince of Wales Hospital in Sydney and completed his training in nuclear medicine, PET and bone densitometry at the Nuclear Medicine and Clinical PET Centre at Guy’s and St Thomas’ Hospitals in London. Dr Wong is on the Bone Densitometry Committee of the Australian and New Zealand Bone and Mineral Society. He is a Senior Lecturer of the School of Medicine at the University of Queensland. He has served as the president of the AANMS and ANZSNM. His research interests include technical performance of DXA instruments, and clinical evaluation of bone density and body composition in disease states with journal publications in these areas.

Lowenthal Lecturer

Marissa BartlettMarissa L. Bartlett

Department of Nuclear Medicine, Royal Brisbane amp; Women's Hospital, Australia

Dr Marissa Bartlett obtained her PhD from the University of Newcatle-Upon-Tyne in England, and undertook post-doctoral work in PET imaging at the National Institutes of Health in the US. She has also held a lectureship in Nuclear Medicine at the Royal Melbourne Institute of Technology. Currently, she is Production Manager of the Radio-isotope Laboratory at the Royal Brisbane & Women’s Hospital, which supports the Dept of Nuclear Medicine and the Specialised PET Services Qld. Professional interests include quantitative imaging, patient dosimetry for radionuclide therapy, and the health effects of radiation.

Pioneer Lecturer

Emlyn JonesDr Emlyn Jones M.B:B.S (Qld) FRACP, FAANMS

Director, Toowoomba Nuclear Imaging, Clinical Senior Lecturer, Department of Medicine, University of Queensland

Emlyn initially trained in Nuclear Medicine at the Royal Brisbane in 1975 / 1976 and subsequently was a Visiting Fellow in Nuclear medicine at Royal Prince Alfred Hospital in Sydney and Sir Charles Gairdner Hospital in Perth. He commenced a regional private nuclear medicine practice at St Andrew's Hospital in Toowoomba in 1984 and is now responsible, as part of Queensland Xray, for busy practices at St Andrew's and St Vincent's Hospital Toowoomba.He is looking forward to the introduction of PET this year.

Emlyn is also a Renal Physician and trained in Renal Medicine at Princess Alexandra Hospital, Brisbane, Royal Victoria Infirmary, Newcastle on Tyne England as well as Victoria Hospital in London,Ontario,Canada. He commenced practice as a Renal Physician in Toowoomba in 1978. In addition to a busy private practice in Renal Medicine and Nuclear Medicine, he was director of the Renal Unit at Toowoomba base Hospital until 2003 when he retired from Renal Medicine. Emlyn is passionate about education and the advancement and advocacy of Nuclear Medicine.